Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dissecting the relationship between antimicrobial peptides and mesenchymal stem cells
Amandda Évelin Silva-Carvalho, Marlon H. Cardoso, Thuany Alencar‐Silva, et al.
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108021-108021
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Bone Marrow Mesenchymal Stem Cell‐Derived Dermcidin‐Containing Migrasomes enhance LC3‐Associated Phagocytosis of Pulmonary Macrophages and Protect against Post‐Stroke Pneumonia
Tiemei Li, Xiaotao Su, Pinglan Lu, et al.
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 29
Potential antibacterial activity and healing effect of topical administration of bone marrow and adipose mesenchymal stem cells encapsulated in collagen-fibrin hydrogel scaffold on full-thickness burn wound infection caused by Pseudomonas aeruginosa
Maryam Mirshekar, Hamed Afkhami, Shabnam Razavi, et al.
Burns (2023) Vol. 49, Iss. 8, pp. 1944-1957
Closed Access | Times Cited: 23
Heterologous Production of Antimicrobial Peptides: Notes to Consider
Masoumeh Kordi, Parnian Ghaedi Talkhounche, Helia Vahedi, et al.
The Protein Journal (2024) Vol. 43, Iss. 2, pp. 129-158
Closed Access | Times Cited: 8
Regulatory Role of Mesenchymal Stem Cells on Secondary Inflammation in Spinal Cord Injury
Qi-Ming Pang, Si-Yu Chen, Sheng-Ping Fu, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 573-593
Open Access | Times Cited: 31
Application of hypoxia-mesenchymal stem cells in treatment of anaerobic bacterial wound infection: wound healing and infection recovery
Elahe Andalib, Mojtaba Kashfi, Golnaz Mahmoudvand, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
Comparison of different sources of mesenchymal stem cells: focus on inflammatory bowel disease
Lingyi Shi, Leilei Chen, Xizhuang Gao, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1721-1742
Closed Access | Times Cited: 5
Mesenchymal Stem Cell-Derived Antimicrobial Peptides as Potential Anti-Neoplastic Agents: New Insight into Anticancer Mechanisms of Stem Cells and Exosomes
Kasra Moeinabadi‐Bidgoli, Malihe Rezaee, Hamidreza Rismanchi, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 21
Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases
Annu Devi, Isha Pahuja, Manisha Singh, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 6, pp. 600-612
Open Access | Times Cited: 12
Advances in Diagnostics and Drug Discovery against Resistant and Latent Tuberculosis Infection
Christian S. Carnero Canales, Jessica Ingrid Marquez Cazorla, André Henrique Furtado Torres, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2409-2409
Open Access | Times Cited: 12
Therapeutic potential of mesenchymal stem cells for fungal infections: mechanisms, applications, and challenges
Yangjie Gao, Zhe Ji, Jingyu Zhao, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Asthma and stem cell therapy
Qionghua Chen, Jing-Yang Zheng, D Wang
World Journal of Stem Cells (2025) Vol. 17, Iss. 2
Closed Access
Combating Antibiotic Resistance: Mechanisms, Multidrug-Resistant Pathogens, and Novel Therapeutic Approaches: An Updated Review
Mostafa E. Elshobary, Nadia K. Badawy, Yara Ashraf Kamel, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 402-402
Open Access
Human β-defensins and their synthetic analogs: Natural defenders and prospective new drugs of oral health
Mumian Chen, Zihe Hu, Jue Shi, et al.
Life Sciences (2024) Vol. 346, pp. 122591-122591
Closed Access | Times Cited: 3
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the “First in Cystic Fibrosis” Phase I Clinical Trial (CEASE-CF)
Tracey L. Bonfield, Morgan T. Sutton, David Fletcher, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 220-220
Open Access | Times Cited: 8
Antimicrobial peptide LL37 and regulatory T cell associated with late-onset sepsis in very preterm infants
Zhuxiao Ren, Yang Shuo, Han Jiangxue, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109780-109780
Open Access | Times Cited: 2
Advancements in Diabetic Foot Ulcer Research: Focus on Mesenchymal Stem Cells and Their Exosomes
Shuhui Wu, Zhongsheng Zhou, Yang Li, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37031-e37031
Open Access | Times Cited: 2
Skin-Derived ABCB5+ Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine
Elke Niebergall‐Roth, Natasha Y. Frank, Christoph Ganss, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 66-66
Open Access | Times Cited: 11
Mesenchymal stromal cell therapy for chronic lung diseases: experimental and clinical evidence
Monique Martins Melo, Fernanda F. Cruz, Patrícia R. M. Rocco
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 3, pp. 223-235
Closed Access | Times Cited: 6
Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19
Xiang-Yi Hou, La-Mu Danzeng, Yilin Wu, et al.
World Journal of Stem Cells (2024) Vol. 16, Iss. 4, pp. 353-374
Open Access | Times Cited: 1
Extracellular vesicles derived from bovine adipose-derived mesenchymal stromal cells enhance in vitro embryo production from lesioned ovaries
Stefhani Martins de Barcelos, Paola Maria da Silva Rosa, Ana Beatriz Bossois Moura, et al.
Cytotherapy (2024) Vol. 26, Iss. 10, pp. 1141-1151
Closed Access | Times Cited: 1
Regulatory T-Cell Enhancement, Expression of Adhesion Molecules, and Production of Anti-Inflammatory Factors Are Differentially Modulated by Spheroid-Cultured Mesenchymal Stem Cells
Amandda Évelin Silva-Carvalho, Ingrid Gracielle Martins da Silva, José R. Corrêa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14349-14349
Open Access | Times Cited: 6
Mesenchymal stem cells: A promising antimicrobial therapy in veterinary medicine
Mudasir Bashir Gugjoo, Qumaila Sakeena, Mohd Yaqoob Wani, et al.
Microbial Pathogenesis (2023) Vol. 182, pp. 106234-106234
Closed Access | Times Cited: 3
IFN‐γ‐Licensed Mesenchymal Stem Cells Are More Susceptible to Death when Exposed to Quorum‐Sensing Signal Molecule OdDHL and Less Effective in Inhibiting the Growth of Pseudomonas aeruginosa
Marielly Reis Resende Sousa, Amandda É. Silva‐Carvalho, Maurício Gonçalves da Costa Sousa, et al.
Stem Cells International (2024) Vol. 2024, Iss. 1
Open Access
Shh Signaling from the Injured Lung Microenvironment Drives BMSCs Differentiation into Alveolar Type II Cells for Acute Lung Injury Treatment in Mice
Mengyu Wu, Jing Liu, Shu Zhang, et al.
Stem Cells International (2024) Vol. 2024, Iss. 1
Open Access
Bacteriocins and Antimicrobial Peptides
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, et al.
(2024), pp. 593-629
Closed Access
Page 1 - Next Page

Scroll to top